$8.000
+0.061 (+0.76%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CRMD Prediction & Forecast by Similar Chart Analysis
Alphio's CRMD stock price prediction model matches the current CorMedix Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.06 (+0.76%). The 1-week path is $7.72 (-3.49%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy CorMedix Inc Stock?
CorMedix Inc (CRMD) is a good buy right now due to its current price of $7.85 and a strong analyst price target of $15.00, suggesting a potential upside of 90.18%. Additionally, the company has shown robust revenue growth, with Q2 revenue reported at $101.9 million, significantly exceeding estimates. However, the main risk is its YTD change of -35.44%, indicating volatility that investors should consider.
CRMD stock price ended at $8.00 on Tuesday, after rising +0.76%
CorMedix Inc (CRMD) last closed at $8, gaining +0.76%. These facts feed the 1-day and 1-week CRMD price prediction above.
Analyst Consensus
CorMedix Inc (CRMD): 1 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
CorMedix Inc (CRMD) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches CRMD, ranked by similarity.
Seasonality analysis for CRMD
Historically the probability of a positive October return for CRMD is 69.70%. November offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.